Trial intelligence / Profile preview

Effect of dronabinol on driving performance in cannabis users

NL-OMON26737Not yet recruiting

Sponsor
Maastricht University
Start
Sep 2009
Modality
Small Molecules
Countries
1
01

Overview

Trial of dronabinol in chronic pain, anorexia nervosa (AN) and chemotherapy-induced nausea and vomiting (CINV) (3 arms), sponsored by Maastricht University. Primary endpoint: Standard deviation of lateral position. Planned start Sep 2009; status: not yet recruiting.

02

Drugs

dronabinol
03

Conditions

chronic painanorexia nervosa (AN)chemotherapy-induced nausea and vomiting (CINV)

Beyond the preview

Go deeper on NL-OMON26737.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON26737.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call